Frequently Asked Questions

PiezoWave2T-Vet shockwave uses a piezoelectric generator in which piezoceramic elements within the therapy source convert electrical energy directly into focused acoustic pressure waves. The focal zone is formed within the tissue itself, allowing precise targeting by depth and energy flux density (EFD). Compared with electrohydraulic and electromagnetic systems, piezoelectric shockwave provides directly focused energy without reflector scatter, greater specificity in EFD and penetration depth, integrated biofeedback, reduced acoustic noise, and improved patient tolerance.

PiezoWave2T VET shockwave acts via mechanotransduction, converting mechanical stimuli into biological responses. At the target tissue, shockwaves promote increased perfusion, growth factor release, and cell proliferation to support tissue healing. It also modulates nociceptive signaling, producing an analgesic effect that typically persists for approximately 72 hours post-treatment.

Yes, with appropriate interpretation. All focused shockwave modalities, electrohydraulic, electromagnetic, and piezoelectric, act through mechanotransduction and initiate the same biological responses when sufficient energy is delivered. However, focal zone size, geometry, and volume differ between technologies so direct protocol matching is not appropriate. When these differences and the reported EFD values are taken into account, published studies can provide valuable protocol insights for clinicians using PiezoWave2T VET shockwave.

Veterinary shockwave devices are regulated medical devices and must be purchased by, or under the authorization of, a licensed veterinarian.

Yes. Veterinary technicians and rehabilitation therapists may administer shockwave therapy, subject to applicable state veterinary practice acts and the protocols of the supervising veterinarian.

Most treatments take approximately 3-15 minutes, depending on the size of the horse and the area treated. A series of 3–6 treatments is commonly recommended to support tissue healing, with sessions typically scheduled every 2 weeks. Regardless of interval, the treatment series should be completed within the appropriate tissue healing window.

PiezoWave2T Vet shockwave can typically be administered with minimal to no discomfort. Most horses tolerate treatment calmly and relax during the session. A small number of patients, particularly those with significant pain, anxiety, or acutely inflamed tissue, may show sensitivity, but energy parameters can be adjusted to maintain patient comfort.

Sedation is rarely required. The PiezoWave2T Vet operates quietly and offers highly customizable parameters that are well tolerated by most equine patients. Because patient feedback helps optimize treatment delivery, it is recommended to treat non-sedated patients when feasible.

In many cases, yes. Because PiezoWave2T Vet is well tolerated, controlled exercise may be resumed the day after treatment, depending on the case, injury, and supervising veterinarian’s judgment.

However, a post-treatment analgesic period of approximately 72 hours is expected. To reduce the risk of injury during this window, horses should not be subjected to high-intensity or uncontrolled exercise until the analgesic effect has resolved.

This depends on the rules of the relevant equine sport or regulatory body and varies by discipline. In many cases, shockwave therapy is prohibited within a defined period prior to competition. These restrictions are intended to reduce the risk of injury during high-intensity activity while post-treatment analgesia remains in effect. Clinicians and owners should consult the applicable rulebook or governing body prior to scheduling treatment around competition.

Most treatments take approximately 3 to 10 minutes, depending on the size of the patient and the area being treated. A series of 3–6 treatments is recommended to support tissue healing, with sessions typically scheduled weekly or every 2 weeks. Regardless of interval, the treatment series should be completed within the appropriate tissue healing window.

PiezoWave2T Vet shockwave can typically be administered with minimal to no discomfort. Most patients tolerate treatment calmly and often relax during the session. A small number of patients, particularly those with significant pain, anxiety, or acutely inflamed tissue, may show sensitivity but energy parameters can be adjusted in real time to maintain patient comfort.

Sedation is rarely necessary. The PiezoWave2T Vet operates quietly and offers highly customizable parameters that are well tolerated by most small animal patients. Because patient biofeedback helps optimize treatment delivery, treating non-sedated patients is recommended when feasible.

Yes. Because treatment is well tolerated, PiezoWave2T therapy can be incorporated into a full rehabilitation visit. Depending on the specific case and the veterinary recommendation patients may participate in controlled therapeutic exercise before or after the shockwave session.